Amgen settles a patent dispute involving a biosimilar version of Stelara.

Published Date: 27 May 2023

According to a filing in Delaware federal court, Johnson and Johnson has resolved its legal dispute with Amgen over Amgen's proposed biosimilar version of J&J's best-selling autoimmune condition treatment Stelara.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot